The National Institute for Health and Clinical Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on balloon dilatation of the Eustachian tube.
The Eustachian tube is a narrow tube that connects the middle ear with the back of the nose. If it is blocked, symptoms such as muffled hearing, pain, a feeling of fullness in the ear, tinnitus or dizziness may occur. In balloon dilatation of the Eustachian tube, a flexible tube with a small balloon is inserted into the Eustachian tube through the nose. The balloon is filled with saline (salt water) and left in place for a short time, with the aim of widening the Eustachian tube.
D22.2 Intubation of eustachian canal
Y76.6 Endonasal endoscopic approach to other body cavity
Y40.3 Balloon dilation of organ NOC
This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully into account, and specifically any special arrangements relating to the introduction of new interventional procedures. The guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.
All problems (adverse events) related to a medicine or medical device used for treatment or in a procedure should be reported to the Medicines and Healthcare products Regulatory Agency using the Yellow Card Scheme.
Commissioners and/or providers have a responsibility to implement the guidance, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties. Providers should ensure that governance structures are in place to review, authorise and monitor the introduction of new devices and procedures.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.